Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized 3% hypertonic saline for acute asthma attack
IRCT2016060526630N2Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of hypertonic saline in asthma, sponsored by Ahvaz Jundishapur University of Medical Sciences. Started May 2014; status: completed.
02
Drugs
hypertonic saline
03
Conditions
asthma
Beyond the preview
Go deeper on IRCT2016060526630N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016060526630N2.